“In-silico Studies of Heterocyclic Benzoxazole Derivatives as an Anticancer Agent: Molecular Docking, 2D and 3D QSAR ”, Int. J. Pharm. Sci. Drug Res., vol. 15, no. 6, pp. 780–788, Nov. 2023, doi: 10.25004/IJPSDR.2023.150612.